Following The Money: Institution’s Growing Stake In Novavax, Inc (NASDAQ: NVAX)
Novavax, Inc (NVAX) concluded trading on Wednesday at a closing price of $7.84, with 12.17 million shares of worth about $95.39 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -11.01% during that period and on July 23, 2025 the price saw a gain […]
Assessing Whether Novavax, Inc (NASDAQ: NVAX) Is Over- Or Undervalued
Novavax, Inc (NVAX) concluded trading on Thursday at a closing price of $7.0, with 4.76 million shares of worth about $33.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -17.70% during that period and on July 17, 2025 the price saw a gain […]
Novavax, Inc (NASDAQ: NVAX) Is Getting Increasingly Hard To Ignore
Currently, there are 161.96M common shares owned by the public and among those 147.54M shares have been available to trade. The company’s stock has a 5-day price change of 11.75% and 12.82% over the past three months. NVAX shares are trading -43.90% year to date (YTD), with the 12-month market performance down to -12.44% lower. […]
Novavax, Inc (NASDAQ: NVAX) – Not A Clear Buying Opportunity?
Novavax, Inc (NVAX) concluded trading on Wednesday at a closing price of $6.76, with 5.45 million shares of worth about $36.83 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -18.36% during that period and on July 02, 2025 the price saw a gain […]
Uncovering Institutional Buying In Novavax, Inc (NASDAQ: NVAX)
Currently, there are 161.96M common shares owned by the public and among those 147.54M shares have been available to trade. The company’s stock has a 5-day price change of -7.68% and -15.60% over the past three months. NVAX shares are trading -53.84% year to date (YTD), with the 12-month market performance down to -19.28% lower. […]
Novavax, Inc (NASDAQ: NVAX): Hunting Genuine Value In Market Debris
Currently, there are 161.96M common shares owned by the public and among those 147.60M shares have been available to trade. The company’s stock has a 5-day price change of -9.86% and -18.36% over the past three months. NVAX shares are trading -19.28% year to date (YTD), with the 12-month market performance down to -56.88% lower. […]
Novavax, Inc (NASDAQ: NVAX) Hogging The Spotlight Today
Currently, there are 161.96M common shares owned by the public and among those 147.60M shares have been available to trade. The company’s stock has a 5-day price change of -0.83% and -9.09% over the past three months. NVAX shares are trading -10.45% year to date (YTD), with the 12-month market performance down to -63.18% lower. […]
Novavax, Inc (NVAX): Street Finally Waking Up
Currently, there are 161.96M common shares owned by the public and among those 147.60M shares have been available to trade. The company’s stock has a 5-day price change of -1.63% and -5.47% over the past three months. NVAX shares are trading -9.70% year to date (YTD), with the 12-month market performance down to -52.39% lower. […]
Investors Should Take Note Of Novavax, Inc (NVAX)
Novavax, Inc (NVAX) concluded trading on Wednesday at a closing price of $6.92, with 7.88 million shares of worth about $54.5 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -13.93% during that period and on Wednesday the price saw a loss of about […]
Novavax, Inc (NVAX) Volatility Spurs A Quest For Clarity
Currently, there are 161.96M common shares owned by the public and among those 147.60M shares have been available to trade. The company’s stock has a 5-day price change of 22.08% and -6.18% over the past three months. NVAX shares are trading -3.73% year to date (YTD), with the 12-month market performance down to -40.00% lower. […]